{
    "clinical_study": {
        "@rank": "142750", 
        "acronym": "GREAT", 
        "arm_group": [
            {
                "arm_group_label": "Decapeptyl\u00ae SR 22.5mg", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Current 3-montly LHRH agonist", 
                "arm_group_type": "Active Comparator", 
                "description": "One of the following: Decapeptyl\u00ae SR 11.25mg, Prostap\u00ae 3 DCS 11.25mg, Zoladex\u00ae LA 10.8mg"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to demonstrate that treatment with a new recently launched\n      6-monthly injection of hormone therapy is as good and as safe as the standard 3-monthly\n      hormone therapy injections available for treating prostate cancer. The study will also aim\n      to answer whether both doctors and patients would prefer treatment with a 6-monthly\n      injection rather than injections every 3 months."
        }, 
        "brief_title": "GP Extended Action Triptorelin", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients must give written (personally signed and dated) informed consent before\n             completing any study related procedure.\n\n          -  Patients must be 18 years old or over.\n\n          -  Patients must have a documented diagnosis of locally advanced or metastatic prostate\n             cancer suitable for hormonal treatment\n\n          -  Patients must be medically castrated with serum testosterone \u2264 0.5ng/mL\n\n          -  Patients must have received at least two injections of a 3- monthly LHRH agonist by\n             the time of the screening tests\n\n          -  Patients must be stable on a 3-monthly LHRH agonist injection with stable PSA levels\n             between screening and baseline (i.e. the baseline value must either be lower or less\n             than 25% higher than the Screening value or if \u226525% higher, \u22640.5ng/mL higher than the\n             screening value).\n\n        In addition:\n\n          -  For patients with locally advanced prostate cancer (M0), LHRH agonist injection (any\n             formulation) must have been initiated within the last 3 years from Baseline,\n\n          -  For patients with metastatic prostate cancer (M+) and a Gleason score\n\n             \u2264 7, LHRH agonist injection (any formulation) must have been initiated within the\n             last 2 years from Baseline,\n\n          -  For patients with metastatic prostate cancer (M+) and a Gleason score > 7, LHRH\n             agonist injection (any formulation) must have been initiated within the last 12\n             months from Baseline.\n\n          -  Patients must have an estimated life expectancy of at least twelve months according\n             to the investigator's assessment.\n\n        Exclusion Criteria:\n\n          -  Patients will not be included in the study if:\n\n          -  Patients have had previous surgical castration.\n\n          -  Patients are, in the opinion of the investigator, unable to comply fully with the\n             protocol and the study instructions.\n\n          -  Patients have received investigational drug(s) or treatment(s) within 30 days prior\n             to study entry or will require a concurrent treatment with any other experimental\n             drugs or treatments.\n\n          -  Patients have had a diagnosis of any other cancer without a history of\n             stability/remission within five years of screening, with the exception of\n             non-metastatic basal cell carcinoma.\n\n          -  Patients currently taking additional anti-androgen therapy as part of an active\n             hormonal control therapy.\n\n          -  Patients scheduled to receive palliative radiotherapy during the course of the study.\n\n          -  Patients receiving an LHRH agonist as neo-adjuvant to radiotherapy or adjuvant to\n             radiotherapy.\n\n          -  Patients receiving LHRH agonist as adjuvant to surgery.\n\n          -  Patients scheduled to undergo radical prostatectomy during the course of the study.\n\n          -  Patients with known hypersensitivity to LHRH agonists, their analogues or any or any\n             other component of the products to be administered."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01673984", 
            "org_study_id": "A-97-52014-181", 
            "secondary_id": "2011-004213-16"
        }, 
        "intervention": [
            {
                "arm_group_label": "Decapeptyl\u00ae SR 22.5mg", 
                "description": "22.5mg, intramuscular injection, given on day 1 / month 0 & month 6 (+/- 7 days).", 
                "intervention_name": "Decapeptyl\u00ae SR 22.5mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Current 3-montly LHRH agonist", 
                "description": "For Decapeptyl\u00ae SR 11.25mg: 11.25 mg, intramuscular injection For Prostap\u00ae 3 DCS 11.25mg: 11.25mg, depot injected subcutaneously For Zoladex\u00ae LA 10.8mg: 10.8mg, depot injected subcutaneously into anterior abdominal wall", 
                "intervention_name": "Decapeptyl\u00ae SR 11.25mg; Prostap\u00ae 3 DCS 11.25mg; Zoladex\u00ae LA 10.8mg", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Goserelin", 
                "Triptorelin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 29, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Addlestone", 
                        "country": "United Kingdom"
                    }, 
                    "name": "The Crouch Oak Family Practice"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ashford", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Dr Carter & Partners"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aylesbury", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Westongrove Research Centre, Aston Clinton Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bath", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Clinical Research Unit, Oldfield Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bath", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Clinical Research Unit, The Pulteney Practice"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bath", 
                        "country": "United Kingdom"
                    }, 
                    "name": "St James' Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Blackpool", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Waterloo Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bury St. Edmunds", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Woolpit Health Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Canterbury", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Cossington House Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chesterfield", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Research Office, Avondale Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chippenham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Clinical Research Unit, Hathaway Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chippenham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Clinical Research Dept., Rowden Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Corsham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "The Porch Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Crawley", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Pound Hill Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Horsley", 
                        "country": "United Kingdom"
                    }, 
                    "name": "The Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hinckley", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Burbage Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hitchin", 
                        "country": "United Kingdom"
                    }, 
                    "name": "The Portmill Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Irvine", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Townhead Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leamington Spa", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Sherbourne Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mortimer", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Mortimer Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantwich", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Kiltearn Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Northampton", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Kingsthorpe Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Northampton", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Danes Camp Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Penzance", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Cape Cornwall Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Penzance", 
                        "country": "United Kingdom"
                    }, 
                    "name": "The Alverton Practice"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Peterborough", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Wansford & Kings Cliffe Practice, Wansford Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plymouth", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Knowle House Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plymouth", 
                        "country": "United Kingdom"
                    }, 
                    "name": "The Rame Group Practice"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sandbach", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Ashfields Primary Care Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Austell", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Brannel Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sunbury-on-Thames", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Sunbury Health Centre Group Practice"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trowbridge", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Adcroft Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Watford", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Sheepcot Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wellingborough", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Albany House Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wokingham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Woosehill Medical Centre"
                }
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase IV, Randomised, Open-label, Multi-centre Study to Assess the Impact on Disease Control, Safety, Patient and Clinician Experience of Changing Patients With Advanced Prostate Cancer From a 3-monthly LHRH Agonist to 6-monthly Injections of Decapeptyl\u00ae SR 22.5 MG", 
        "overall_official": {
            "affiliation": "Ipsen", 
            "last_name": "Anne Fairey, M.D.", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "A difference of less than 7.5% between the two treatment arms is considered to be not clinically relevant.", 
            "measure": "Change from baseline in the percentage of participants who maintain biochemical castration", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01673984"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in the percentage of participants who demonstrating stable prostate-specific antigen (PSA) levels", 
                "safety_issue": "No", 
                "time_frame": "6 and 12 months"
            }, 
            {
                "measure": "Change from baseline in quality of life measured using EQ-5D-5L", 
                "safety_issue": "No", 
                "time_frame": "Month 12"
            }, 
            {
                "measure": "Patient satisfaction with medication using Treatment Satisfaction Questionnaire for Medication (TSQM version II)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, month 6 and 12"
            }, 
            {
                "measure": "Patient satisfaction with treatment using a non-validated study-specific Likert-type scale", 
                "safety_issue": "No", 
                "time_frame": "Month 12"
            }, 
            {
                "measure": "The percentage of participants who remain on the same formulation of LHRH agonist as their study treatment", 
                "safety_issue": "No", 
                "time_frame": "Month 12"
            }, 
            {
                "measure": "Change from baseline in the percentage of participants who maintain biochemical castration", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Ipsen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ipsen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}